Success Stories: An Indian Senior Research Associate in Molecular Biology Received Her EB-1B in 14 Days Only with Our Expert Advice, Premium Processing Requested
Client’s Testimonial:
“Thank you for all your work in getting the I-140 application process.”
On August 9th, 2021, we received another EB-1B (Outstanding Professors and Researchers) approval for a Senior Research Associate in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Senior Research Associate
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: August 9th, 2021
Processing Time: 14 days (Premium Processing Requested)
Case Summary:
Whenever we at North America Immigration Law Group receive a request for filing an EB-1B (Outstanding Professors and Researchers) petition, we take care to be thorough in our research of the client’s academic and professional standing in the international community. Since the EB-1B is a subcategory of the priority worker, the qualifying criteria for it are very clear-cut and competitive. So, when a senior research associate working in the field of molecular biology from India approached us, we took every care to build a solid case for her outstanding ability. Because her specialized research has focused on developing improved diagnostic technologies for infectious diseases, her research addressed some of the U.S.’s most pressing issues in understanding improved means for diagnosing Lyme Disease, tick-borne relapsing fever, and malaria, among other infectious illnesses. We found that with an M.S. in cellular and molecular biology, she was a highly qualified advanced degree scientist with extensive experience in developing diagnostic techniques for infectious diseases.
We then used this information to corroborate other information that she had provided us, such as her publication record, her citation counts, and her peer review experience.
- We highlighted that her work had resulted in 9 peer-reviewed scientific articles and 1 patent. Her work has been published in some of the most prestigious, high-impact journals in her field internationally.
- Moreover, her work has been cited 274 times in several peer-reviewed journal articles according to Google Scholar. These citations come from independent and leading researchers from prestigious institutions and organizations around the world.
- She has also been active in the scientific community as a peer reviewer for highly acclaimed journals. That is, she has already conducted at least 2 reviews. Only top-level experts in their field are invited to perform this important review work, thus demonstrating her significance.
- We demonstrated that she qualified the offer of employment criteria by attaching a copy of her current employment letter. She was offered employment by a leading U.S.-based company to work with them as a research associate, a position that began in 2013. She was then appointed to her current position of senior research associate in 2019.
“[The client’s] Lyme disease research, coupled with her noteworthy advancements in disease diagnostics, have set her apart as a prominent molecular biologist working at the forefront of her field. As her work is also of paramount importance to the U.S. medical sector, her talents and expertise must be retained without delay.”
We were thus delighted to hear from USCIS after only 14 days of deliberation when we received her approval notice. We are thankful to her for choosing our firm to represent her in this case and retaining us for her I-485 petition.